The International Society for Stem Cell Research (ISSCR) led a group of scientists to Washington, DC, U.S. on 18 September, 2019 to garner support for policies important to stem cell research and the broader biomedical research community. The scientists met with representatives from 16 Congressional Offices to discuss the protection of fetal tissue research, the need for additional enforcement to curb the marketing and use of unproven products, and the importance of NIH funding for biomedical research. Former ISSCR President Sally Temple, who has previously spoken on Capitol Hill regarding the importance of fetal tissue as a tool for biomedical research, said “It is important for the scientific community to have a voice with policymakers and regulators as they consider issues that impact us, our research and ultimately the many patients that can and will benefit from stem cell and biomedical research. Effective advocacy requires a sustained effort across the globe and the ISSCR is well-positioned to lead these efforts.”
Pictured from left to right, Zubin Master (Mayo Clinic), Martin Pera (The Jackson Laboratory),
Representative Jared Golden (Maine), Tenneille Ludwig (WiCell), Chris Barry (ISSCR).
Pictured from left to right, Deepak Srivastava (Gladstone Institutes, ISSCR President),
Admiral Brett Giroir (U.S. Health and Human Services), Arnold Kriegstein
(University of California, San Francisco), Sean Morrison (UT Southwestern).
Pictured from left to right, Sally Temple (Neural Stem Cell Institute), Melissa Carpenter
(Carpenter Group Consulting) and Charles Murry (University of Washington).